News

FibroGen Gains Approval for Subsidiary Sale to AstraZeneca

Detailed price information for Fibrogen Inc CS (FGEN-Q) from The Globe and Mail including charting and trades.

FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation

Sale of FibroGen China remains on track to close in 3Q 2025 SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the China State Administration for ...
Stocktwits on MSN2d

Fibrogen Gets Regulator’s Green Light To Sell China Unit To AstraZeneca

FibroGen, Inc. (FGEN) on Monday said that a Chinese regulator has approved the sale of its unit FibroGen International (Hong ...

FibroGen Second Quarter 2025 Earnings: Misses Expectations

Second Quarter 2025 Results Key Financial Results Net loss: US$13.7m (loss narrowed by ...
TipRanks on MSN2d

FibroGen announces approval for FibroGen China sale to AstraZeneca

FibroGen (FGEN) announced that the China State Administration for Market Regulation approved the sale of FibroGen International to AstraZeneca ...
The Globe and Mail1d

Barclays Keeps Their Buy Rating on AstraZeneca (AZN)

Barclays analyst Shirley Chen maintained a Buy rating on AstraZeneca today and set a price target of £140.00. The company’s shares closed yesterday at p11,738.00. Take advantage of TipRanks Premium at ...